ArticleFrontiers in cardiovascular medicine2025
Prognostic value of the triglyceride-glucose index for major adverse events in acute aortic dissection patients.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prognostic value of insulin resistance (IR) indices in patients with acute aortic dissection (AAD) remains unclear. This study investigated the associations between four IR indices and major adverse cardiac and cerebrovascular events (MACCEs) in AAD patients. Methods: We retrospectively analyzed 114 AAD patients from Henan Chest Hospital (December 2017-December 2023). Four IR indices were calculated: triglyceride-glucose (TyG) index, TyG-BMI index, TG/HDL-C ratio, and METS-IR. Multivariable logistic regression models were constructed to evaluate associations with MACCEs. Subgroup analyses were performed in male, hypertensive, diabetic, and smoking patients. Results: Among 114 patients (mean age 50.67 ± 12.49 years), 55 (48.2%) developed MACCEs. In fully adjusted models, only TyG index independently predicted MACCEs (OR = 2.46, 95% CI: 1.24-4.90, Conclusions: An elevated TyG index independently predicts MACCEs in AAD patients, particularly in males and smokers, and may support risk stratification and intensified follow-up in high-risk individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.